Featured Article Why Is My Pet Gaining Weight? Cover Story PetIQ Acquires MYOS to Expand Muscle Health Product expansion Parnell Adds 50 mL PropofolVet Multidose Corporate update PetVivo Ends VetStem Partnership Private equity Artá Capital Invests in Magapor Strategic Acquisition LIMPID Co...
Featured Article Cover Story Product launch Clinical data Retail pharmacy FDA Launches Animal Drug Manufacturing Pilot Regulatory update The FDA’s Center for Veterinary Medicine has launched a pilot program to speed review of animal drug applications when both the finished product and acti...
Featured Article Understanding Pet Food Labels: What Every Pet Owner Should Know Cover Story Investment Product Launch Product Expansion Partnership Clinical Study Regulatory Updates Zoetis Acquires VitalRADS Acquisition Zoetis has agreed to acquire VitalRADS to expand its veterinary diagn...
Featured Article Cover Story Product Launch Partnership Research Updates Regulatory Updates Bond Vet and Small Door Veterinary Complete Merger Corporate transaction Bond Vet and Small Door Veterinary have completed their merger, creating one of the largest premium veterinary care networks ...
Featured Article Cover Story Regulatory Updates Launch Product Launch PetMeds Receives New Acquisition Proposal Corporate transaction PetMed Express has received an unsolicited, non-binding proposal from SilverCape Investments to acquire all outstanding shares for $3.00 per share in cash. ...
Featured Article Cover Story Regulatory Updates Research Updates Product Launch Retail expansion Dechra Opens Global Headquarters in Boston Corporate update Dechra has opened its new global headquarters in Boston, strengthening its innovation footprint while supporting community programs t...
Quick Takeaways: Why It Matters? Dechra’s Boston HQ move and community-facing strategy signal how veterinary pharma is increasingly aligning with mainstream human health and life sciences ecosystems, not just traditional animal-health hubs, which could intensify competition for talent, par...
Featured Article Cover Story Research Updates Regulatory Approval Product Launches Elanco Launches $25 Million Venture Fund Innovation platform Elanco Animal Health plans to launch Elanco Ventures, a $25 million corporate venture platform to back early-stage animal health innovation. Key h...
The US FDA’s 2025 animal health approvals highlight a transformative year for veterinary medicine, with major advances spanning companion animal therapeutics, livestock productivity, poultry health, parasitic disease management, diagnostics, oncology, and genetic innovation. The latest wav...
Quick Takeaways: Why It Matters? Elanco Ventures adds a structured, early-stage venture arm to Elanco’s strategy, giving the company a dedicated channel to access and co-develop emerging animal health technologies before they become mature competitors or acquisition targets. The ...
